CCM
MRK icon

Chiron Capital Management’s Merck MRK Stock Holding History

Chiron Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
1,827
-6,712
-79% -$786K 0.21% 116
2026
Q1 		$1.03M Buy
+8,539
New +$986K 1.05% 25
2025
Q3 		$2.41M Sell
28,728
-923
-3% -$76K 2.06% 8
2025
Q2 		$2.35M Buy
29,651
+11,412
+63% +$907K 2.04% 7
2025
Q1 		$1.64M Buy
18,239
+8,005
+78% +$747K 1.49% 14
2024
Q4 		$1.02M Buy
10,234
+6,623
+183% +$683K 0.96% 25
2024
Q3 		$410K Buy
3,611
+911
+34% +$108K 0.36% 70
2024
Q2 		$334K Hold
2,700
– – 0.32% 78
2024
Q1 		$356K Sell
2,700
-300
-10% -$37K 0.32% 72
2023
Q4 		$327K Sell
3,000
-302
-9% -$31.3K 0.28% 79
2023
Q3 		$340K Buy
3,302
+1
+0% +$108 0.29% 79
2023
Q2 		$381K Buy
3,301
+196
+6% +$22.3K 0.3% 68
2023
Q1 		$330K Sell
3,105
-900
-22% -$97.2K 0.23% 82
2022
Q4 		$444K Sell
4,005
-4,600
-53% -$470K 0.31% 60
2022
Q3 		$741K Sell
8,605
-1,898
-18% -$169K 0.5% 51
2022
Q2 		$958K Sell
10,503
-6,399
-38% -$567K 0.6% 39
2022
Q1 		$1.39M Buy
16,902
+1,301
+8% +$103K 0.87% 23
2021
Q4 		$1.2M Sell
15,601
-7,899
-34% -$629K 0.86% 23
2021
Q3 		$1.76M Buy
23,500
+2,650
+13% +$202K 1.29% 12
2021
Q2 		$1.62M Sell
20,850
-1,787
-8% -$133K 1.35% 13
2021
Q1 		$1.67M Buy
22,637
+13,722
+154% +$1.01M 1.41% 12
2020
Q4 		$696K Buy
8,915
+2,206
+33% +$169K 0.57% 29
2020
Q3 		$531K Buy
+6,709
New +$526K 0.43% 36

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

Chiron Capital Management's MRK Position: Q2 2026 in Review

Chiron Capital Management reduced its Merck (MRK) stake by 79% in Q2 2026, selling an estimated $786K and leaving 1,827 shares worth $235K. The position accounts for 0.21% of the portfolio, ranked #116.

Chiron Capital Management first reported a position in MRK in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.41M in Q3 2025. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chiron Capital Management held 1,827 shares of Merck worth $235K as of Q2 2026.
  • Chiron Capital Management sold 6,712 Merck shares in Q2 2026, an estimated $786K.
  • Merck made up 0.21% of Chiron Capital Management's portfolio in Q2 2026, its #116 holding.
  • Chiron Capital Management first reported a position in Merck in Q3 2020 and has held it in 23 quarters since.
  • Chiron Capital Management's Merck position peaked at $2.41M in Q3 2025.
  • 924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.